FEBS Letters
Volume 581, Issue 28 , Pages 5459-5463, 27 November 2007

A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32–C36 acyl phosphatidylcholines

Edited by Sandro Sonnino

  • Anne McMahon

      Affiliations

    • Department of Ophthalmology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
  • ,
  • Shelley N. Jackson

      Affiliations

    • National Institute on Drug Abuse, Intramural Research Program, National Institute of Health, Baltimore, MD 21224, USA
  • ,
  • Amina S. Woods

      Affiliations

    • National Institute on Drug Abuse, Intramural Research Program, National Institute of Health, Baltimore, MD 21224, USA
  • ,
  • Wojciech Kedzierski

      Affiliations

    • Department of Ophthalmology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    • Corresponding Author InformationCorresponding author. Fax: +1 214 648 2382.

Received 27 September 2007; received in revised form 25 October 2007; accepted 26 October 2007. published online 05 November 2007.

Abstract 

Stargardt disease-3 (STGD3) is a juvenile dominant macular degeneration caused by mutations in elongase of very long chain fatty acid-4. All identified mutations produce a truncated protein which lacks a motif for protein retention in endoplasmic reticulum, the site of fatty acid synthesis. In these studies of Stgd3-knockin mice carrying a human pathogenic mutation, we examined two potential pathogenic mechanisms: truncated protein-induced cellular stress and lipid product deficiency. Analysis of mutant retinas detected no cellular stress but demonstrated selective deficiency of C32–C36 acyl phosphatidylcholines. We conclude that this deficit leads to the human STGD3 pathology.

Abbreviations: AMD, age-related macular degeneration, DHA, docosahexaenoic acid, ELOVL4, elongase of very long chain fatty acid-4, ER, endoplasmic reticulum, MS, mass spectrometry, m/z, mass-to-charge ratio, N, nucleotide, PC, phosphatidylcholine, STGD3, Stargardt disease-3

Keywords: Stargardt disease-3, Retina, Very long chain fatty acid, Phosphatidylcholine, Unfolded-protein response, Mass spectrometry

 

PII: S0014-5793(07)01118-0

doi:10.1016/j.febslet.2007.10.050

FEBS Letters
Volume 581, Issue 28 , Pages 5459-5463, 27 November 2007